About Kypha
Kypha is a company based in Saint Louis (United States) founded in 2009.. Kypha has raised $16.76 million across 14 funding rounds from investors including HHS, Arsenal Capital Partners and Arsenal Capital Management. Kypha has completed 1 acquisition, including Biosensia. Kypha offers products and services including RapiPlex™, Comp ACT®, Assay Development, and Custom Panel Development. Kypha operates in a competitive market with competitors including HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Immudex, among others.
- Headquarter Saint Louis, United States
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Kypha
Kypha offers a comprehensive portfolio of products and services, including RapiPlex™, Comp ACT®, Assay Development, and Custom Panel Development. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Enables simultaneous quantitative multiplex analysis from biological samples.
Offers quantitative single analyte measurement with minimal sample volume.
Supports bioanalytical needs for safety monitoring and diagnostics.
Creates tailored panels for specific protein analysis in research.
Unlock access to complete
Unlock access to complete
Funding Insights of Kypha
Kypha has successfully raised a total of $16.76M across 14 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in December 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Series A — $4.0M
-
First Round
First Round
(01 Jul 2009)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Dec, 2018 | Amount | Series A - Kypha | Valuation | Arsenal Capital Management |
|
| Jul, 2018 | Amount | Series A - Kypha | Valuation |
investors |
|
| May, 2018 | Amount | Series A - Kypha | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Kypha
Kypha has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, Arsenal Capital Partners and Arsenal Capital Management. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Private equity investments target specialty industrials and healthcare sectors.
|
Founded Year | Domain | Location | |
|
Venture capital fund focused on Agtech and multiple sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Kypha
Kypha has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Biosensia. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Point-of-care in vitro diagnostics platform for immunoassays is developed.
|
2006 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Kypha
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Kypha Comparisons
Competitors of Kypha
Kypha operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as HYCOR BioMedical, Exagen, Lophius Biosciences, PredictImmune and Immudex, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of diagnostic instruments and reagents for autoimmune diseases and allergies
|
|
| domain | founded_year | HQ Location |
Diagnostic and monitoring solutions for autoimmune connective diseases are developed.
|
|
| domain | founded_year | HQ Location |
T-cell-based diagnostics for infectious and immune diseases are developed.
|
|
| domain | founded_year | HQ Location |
Tools for diagnosing immune-mediated inflammatory diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of immune monitoring reagents and services for research and clinical use
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Kypha
Frequently Asked Questions about Kypha
When was Kypha founded?
Kypha was founded in 2009.
Where is Kypha located?
Kypha is headquartered in Saint Louis, United States. It is registered at Saint Louis, Missouri, United States.
Is Kypha a funded company?
Kypha is a funded company, having raised a total of $16.76M across 14 funding rounds to date. The company's 1st funding round was a Series A of $5.46M, raised on Jul 01, 2009.
What does Kypha do?
Kypha was founded in 2009 in Saint Louis, United States, and operates in the in-vitro diagnostics sector focused on inflammation and autoimmune conditions. Innovative biomarker tests are discovered, developed, and commercialized for indications such as lupus, stroke, traumatic brain injury, preeclampsia, infection, kidney disease, and transplant rejection. The COMP ACT System is utilized to detect and quantify inflammatory status through complement-related biomarkers, enabling monitoring over time.
Who are the top competitors of Kypha?
Kypha's top competitors include Exagen, SmartHealth and HYCOR BioMedical.
What products or services does Kypha offer?
Kypha offers RapiPlex™, Comp ACT®, Assay Development, and Custom Panel Development.
How many acquisitions has Kypha made?
Kypha has made 1 acquisition, including Biosensia.
Who are Kypha's investors?
Kypha has 7 investors. Key investors include HHS, Arsenal Capital Partners, Arsenal Capital Management, Serra Ventures, and BioGenerator Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.